Price T Rowe Associates Inc. MD decreased its stake in Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 32.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,213 shares of the medical instruments supplier's stock after selling 7,227 shares during the quarter. Price T Rowe Associates Inc. MD owned approximately 0.45% of Utah Medical Products worth $936,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of the stock. Golden State Wealth Management LLC acquired a new stake in shares of Utah Medical Products in the 4th quarter valued at $31,000. Bessemer Group Inc. acquired a new position in Utah Medical Products in the fourth quarter valued at about $31,000. Tower Research Capital LLC TRC grew its stake in Utah Medical Products by 172.6% during the fourth quarter. Tower Research Capital LLC TRC now owns 518 shares of the medical instruments supplier's stock worth $32,000 after buying an additional 328 shares during the last quarter. R Squared Ltd acquired a new stake in shares of Utah Medical Products during the fourth quarter worth approximately $49,000. Finally, New Age Alpha Advisors LLC bought a new position in shares of Utah Medical Products in the fourth quarter valued at approximately $101,000. 69.60% of the stock is currently owned by institutional investors.
Utah Medical Products Trading Up 1.3%
NASDAQ UTMD traded up $0.69 during trading hours on Tuesday, reaching $54.71. 9,261 shares of the company's stock were exchanged, compared to its average volume of 20,007. The firm has a fifty day moving average of $54.84 and a 200-day moving average of $59.91. Utah Medical Products, Inc. has a one year low of $51.26 and a one year high of $77.33. The stock has a market cap of $179.56 million, a PE ratio of 13.85 and a beta of 0.30.
Utah Medical Products (NASDAQ:UTMD - Get Free Report) last announced its earnings results on Tuesday, April 29th. The medical instruments supplier reported $0.92 EPS for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%. The company had revenue of $9.71 million for the quarter.
Utah Medical Products Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 3rd. Shareholders of record on Monday, June 16th will be given a $0.305 dividend. This represents a $1.22 annualized dividend and a yield of 2.23%. The ex-dividend date is Monday, June 16th. Utah Medical Products's payout ratio is presently 32.28%.
Utah Medical Products Profile
(
Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Featured Articles
Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
